In addition, nearly 32% of people taking Zepbound lost at least a quarter of their body weight, compared to about 16% of those taking Wegovy, the study found
If a dose is missed, the patient should skip that dose and take the next scheduled dose the following day
Oral semaglutide is a tablet that helps manage blood sugar and support weight loss
1 About Wegovy (semaglutide 2.4 mg) Wegovy (once-weekly subcutaneous semaglutide 2.4 mg) is a GLP-1 receptor agonist indicated as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adults with a BMI of 30 kg/m 2 or greater (obesity), adults with a BMI of 27 kg/m 2 or greater (overweight) in the presence of at least one weight-related comorbid condition, and paediatric patients aged 12 years and older with an initial BMI at the 95th percentile or greater for age and gender (obesity) 8
compiled from community dosing logs and reconstitution guides documentation of what sources describe, not a recommendation): Self-reported starting doses begin around 125 mcg weekly for 2-4 weeks to assess tolerance, before increasing to 250 mcg